Literature DB >> 7553888

Induction of IL-6 and IL-10 production by recombinant HIV-1 envelope glycoprotein 41 (gp41) in the THP-1 human monocytic cell line.

S Takeshita1, E C Breen, M Ivashchenko, P G Nishanian, T Kishimoto, D L Vredevoe, O Martinez-Maza.   

Abstract

Elevated levels of circulating monokines (IL-6, IL-1, and TNF alpha) have been seen in HIV-1 infection, and the overproduction of these cytokines could contribute to AIDS pathogenesis in various ways. In previous work, we had seen that exposure of human monocytes to HIV-1, including inactivated, noninfectious HIV, led to rapid IL-6 gene expression and secretion. To investigate cytokine production in response to components of HIV by monocytes/macrophages, production of IL-6 and IL-10 were examined in a human monocytic cell line, THP-1, stimulated by HIV proteins. IL-6 production was induced in THP-1 cells by a detergent lysate of HIV, particularly fractions at molecular weight of 25-50 kDa. Recombinant HIV envelope glycoprotein 41 (gp41), but not gp120 or p24, also was seen to induce significant IL-6 production by THP-1 cells. These results suggest that gp41, transmembrane protein, is the primary HIV-encoded protein involved in inducing IL-6 production. IL-10 was also produced with delayed kinetics, following IL-6 production in THP-1 cells stimulated by gp41. To investigate a possible regulatory role for IL-10 in HIV-induced monokine production, recombinant IL-10 was added to gp41-exposed THP-1 cells. IL-10 inhibited gp41-induced IL-6 production and reduced the expression of IL-6 mRNA. When anti-human IL-10 neutralizing antibody was added to THP-1 cells, IL-6 production was enhanced. These results suggest that the IL-6 production may be downregulated by endogenously produced IL-10 and that IL-10 may downregulate cytokine production by HIV-activated monocytes via an autoregulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553888     DOI: 10.1006/cimm.1995.1210

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  13 in total

1.  HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.

Authors:  H Ueda; O M Howard; M C Grimm; S B Su; W Gong; G Evans; F W Ruscetti; J J Oppenheim; J M Wang
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

2.  Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system.

Authors:  C Gemma; E M Smith; T K Hughes; M R Opp
Journal:  Cell Mol Neurobiol       Date:  2000-08       Impact factor: 5.046

Review 3.  Diagnosis and management of lymphomas and other cancers in HIV-infected patients.

Authors:  Antonino Carbone; Emanuela Vaccher; Annunziata Gloghini; Liron Pantanowitz; Akin Abayomi; Paolo de Paoli; Silvia Franceschi
Journal:  Nat Rev Clin Oncol       Date:  2014-03-11       Impact factor: 66.675

4.  Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components.

Authors:  D Delfino; L Cianci; E Lupis; A Celeste; M L Petrelli; F Curró; V Cusumano; G Teti
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: involvement of interleukin-1beta production by microglia.

Authors:  S Hu; H Ali; W S Sheng; L C Ehrlich; P K Peterson; C C Chao
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

6.  B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.

Authors:  Elizabeth Crabb Breen; Shehnaz K Hussain; Larry Magpantay; Lisa P Jacobson; Roger Detels; Charles S Rabkin; Richard A Kaslow; Daina Variakojis; Jay H Bream; Charles R Rinaldo; Richard F Ambinder; Otoniel Martinez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-28       Impact factor: 4.254

7.  HIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cells.

Authors:  Manuela Del Cornò; Gloria Donninelli; Barbara Varano; Letizia Da Sacco; Andrea Masotti; Sandra Gessani
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

8.  Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.

Authors:  Elena Vendrame; Shehnaz K Hussain; Elizabeth Crabb Breen; Larry I Magpantay; Daniel P Widney; Lisa P Jacobson; Daina Variakojis; Emilee R Knowlton; Jay H Bream; Richard F Ambinder; Roger Detels; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-12       Impact factor: 4.254

Review 9.  Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection.

Authors:  Maria R Petrara; Riccardo Freguja; Ketty Gianesin; Marisa Zanchetta; Anita De Rossi
Journal:  Front Microbiol       Date:  2013-10-18       Impact factor: 5.640

10.  Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1.

Authors:  Joachim Denner; Magdalena Eschricht; Michael Lauck; Marwan Semaan; Philipp Schlaermann; Hyunmi Ryu; Levent Akyüz
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.